首页 > 最新文献

Evidence-based practice : patient-oriented evidence that matters最新文献

英文 中文
Is acceptance and commitment therapy effective in addressing critical outcomes associated with cancer survivorship? 接受和承诺治疗在解决与癌症生存相关的关键结果方面有效吗?
Pub Date : 2020-06-01 DOI: 10.1097/ebp.0000000000000809
Alex Kirk, Vanessa Rollins, Joanna J Arch
The Evidence ACT is a cognitive behavioral intervention focused on enhancing psychological flexibility, which refers to the ability to recognize and adapt to situational demands, to shift mindsets or responses when personal or social functioning is compromised, and to remain open and committed to behaviors that reflect personally chosen values. Although ACT has been found effective in various psychological disorders, its application to psychosocial concerns and health behavior change in medical populations is relatively new. The cancer experience has become an important focus for behavioral interventions because of its negative impact on outcomes associated with both mental and physical health, including increased anxiety and depression, physical pain, fatigue, and reduced physical activity. Furthermore, a recent survey indicated that cancer survivors prefer behavioral interventions for distress over taking psychiatric medication, a preference that is largely unmet. Compared with traditional cognitive behavioral treatments, ACT is uniquely designed to promote shifting away from efforts to get rid of psychological symptoms and toward living in accordance with personal values (who and what one most cares about) within the context of whatever life brings. An approach such as ACT that allows for distress may be well-suited to cancer survivors, whose distress frequently reflects realistic concerns, including fear and reality of cancer recurrence or metastasis, enduring treatment side effects, and the need to change major health behaviors (eg, lose weight, stop smoking). A recent review of 19 studies that included 10 randomized and five nonrandomized trials with 1,545 cancer survivors found that ACT has improved outcomes associated with cancer survivorship. ACT reduced anxiety (7 of 7 trials) and depression (9 of 9 trials), and increased quality of life (5 of 5 trials) and psychological flexibility (11 of 11 trials). In physical health outcomes, a randomized trial with 410 colorectal cancer survivors found that, relative to a group receiving educational brochures on reducing cancer risk as well as dietary and physical activity information, an ACT-based telephone-delivered intervention improved physical activity by 28.5 minutes per week (P5.003), body mass index by –0.9 kg/m (P5.001), and reduced total fat intake by 7% per day (P5.006), including lowering saturated fat intake by 2.8% per day (P5.016), and increasing vegetable intake by 0.4 servings per day (P5.001), with improvements sustained at a 12-month follow-up. In addition, a single-arm pilot study of 42 cancer survivors found that a seven-week ACT group intervention was associated with improvements across a broader range of outcomes based on Cohen’s d effect sizes, including large improvements in anxiety (State-Trait Anxiety Inventory, d51.00, P,.001), depression (Center for Epidemiological Studies Depression Scale, d50.95, P,.001), and cancer-related trauma symptoms (Revised Impact of Events Sc
{"title":"Is acceptance and commitment therapy effective in addressing critical outcomes associated with cancer survivorship?","authors":"Alex Kirk, Vanessa Rollins, Joanna J Arch","doi":"10.1097/ebp.0000000000000809","DOIUrl":"https://doi.org/10.1097/ebp.0000000000000809","url":null,"abstract":"The Evidence ACT is a cognitive behavioral intervention focused on enhancing psychological flexibility, which refers to the ability to recognize and adapt to situational demands, to shift mindsets or responses when personal or social functioning is compromised, and to remain open and committed to behaviors that reflect personally chosen values. Although ACT has been found effective in various psychological disorders, its application to psychosocial concerns and health behavior change in medical populations is relatively new. The cancer experience has become an important focus for behavioral interventions because of its negative impact on outcomes associated with both mental and physical health, including increased anxiety and depression, physical pain, fatigue, and reduced physical activity. Furthermore, a recent survey indicated that cancer survivors prefer behavioral interventions for distress over taking psychiatric medication, a preference that is largely unmet. Compared with traditional cognitive behavioral treatments, ACT is uniquely designed to promote shifting away from efforts to get rid of psychological symptoms and toward living in accordance with personal values (who and what one most cares about) within the context of whatever life brings. An approach such as ACT that allows for distress may be well-suited to cancer survivors, whose distress frequently reflects realistic concerns, including fear and reality of cancer recurrence or metastasis, enduring treatment side effects, and the need to change major health behaviors (eg, lose weight, stop smoking). A recent review of 19 studies that included 10 randomized and five nonrandomized trials with 1,545 cancer survivors found that ACT has improved outcomes associated with cancer survivorship. ACT reduced anxiety (7 of 7 trials) and depression (9 of 9 trials), and increased quality of life (5 of 5 trials) and psychological flexibility (11 of 11 trials). In physical health outcomes, a randomized trial with 410 colorectal cancer survivors found that, relative to a group receiving educational brochures on reducing cancer risk as well as dietary and physical activity information, an ACT-based telephone-delivered intervention improved physical activity by 28.5 minutes per week (P5.003), body mass index by –0.9 kg/m (P5.001), and reduced total fat intake by 7% per day (P5.006), including lowering saturated fat intake by 2.8% per day (P5.016), and increasing vegetable intake by 0.4 servings per day (P5.001), with improvements sustained at a 12-month follow-up. In addition, a single-arm pilot study of 42 cancer survivors found that a seven-week ACT group intervention was associated with improvements across a broader range of outcomes based on Cohen’s d effect sizes, including large improvements in anxiety (State-Trait Anxiety Inventory, d51.00, P,.001), depression (Center for Epidemiological Studies Depression Scale, d50.95, P,.001), and cancer-related trauma symptoms (Revised Impact of Events Sc","PeriodicalId":93430,"journal":{"name":"Evidence-based practice : patient-oriented evidence that matters","volume":"23 6","pages":"8-9"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/ebp.0000000000000809","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39898215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Evidence-based practice : patient-oriented evidence that matters
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1